» Authors » Rebecca N Gray

Rebecca N Gray

Explore the profile of Rebecca N Gray including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 299
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McCrory D, Gray R
Cochrane Database Syst Rev . 2012 Feb; (2):CD002915. PMID: 22336784
Background: Migraine is a common neurovascular disorder characterized by recurrent episodes of disabling headache, autonomic nervous system dysfunction, and, in some patients, neurological aura symptoms. Sumatriptan is one of a...
2.
Powers B, Coeytaux R, Dolor R, Hasselblad V, Patel U, Yancy Jr W, et al.
J Gen Intern Med . 2011 Dec; 27(6):716-29. PMID: 22147122
Objectives: A 2007 systematic review compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in patients with hypertension. Direct renin inhibitors (DRIs) have since been introduced, and significant...
3.
Coeytaux R, Williams Jr J, Gray R, Wang A
Ann Intern Med . 2010 Aug; 153(5):314-24. PMID: 20679543
Surgical aortic valve replacement (SAVR) is the only treatment known to improve symptoms and survival in patients with severe, symptomatic aortic stenosis. Perioperative mortality, however, is high among many patients...
4.
Thakur M, Grossman I, McCrory D, Orlando L, Steffens D, Cline K, et al.
Genet Med . 2007 Dec; 9(12):826-35. PMID: 18091432
Purpose: Cytochrome P450 (CYP450) enzymes metabolize selective serotonin reuptake inhibitor (SSRI) drugs used in treatment of depression. Variants in these genes may impact treatment efficacy and tolerability. The purpose of...
5.
Matchar D, McCrory D, Orlando L, Patel M, Patel U, Patwardhan M, et al.
Ann Intern Med . 2007 Nov; 148(1):16-29. PMID: 17984484
Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown. Purpose: To compare the benefits and harms of ACE...
6.
Myers E, Bastian L, Havrilesky L, Kulasingam S, Terplan M, Cline K, et al.
Evid Rep Technol Assess (Full Rep) . 2007 Sep; (130):1-145. PMID: 17854238
Objectives: To assess diagnostic strategies for distinguishing benign from malignant adnexal masses. Data Sources: MEDLINE(R) and reference lists of recent reviews; discharge data from the Nationwide Inpatient Sample. Review Methods:...
7.
Patwardhan M, Samsa G, McCrory D, Fisher D, Mantyh C, Morse M, et al.
Evid Rep Technol Assess (Full Rep) . 2007 Sep; (138):1-116. PMID: 17764215
Objectives: To identify measures that are currently available to assess the quality of care provided to patients with colorectal cancer (CRC), and to assess the extent to which these measures...
8.
Matchar D, Thakur M, Grossman I, McCrory D, Orlando L, Steffens D, et al.
Evid Rep Technol Assess (Full Rep) . 2007 Sep; (146):1-77. PMID: 17764209
Objectives: To determine if testing for cytochrome P450 (CYP450) polymorphisms in adults entering selective serotonin reuptake inhibitor (SSRI) treatment for non-psychotic depression leads to improvement in outcomes, or if testing...
9.
Myers E, Havrilesky L, Kulasingam S, Sanders G, Cline K, Gray R, et al.
Evid Rep Technol Assess (Full Rep) . 2007 Sep; (145):1-100. PMID: 17764207
Objectives: To assess the evidence that the use of genomic tests for ovarian cancer screening, diagnosis, and treatment leads to improved outcomes. Data Sources: PubMed and reference lists of recent...
10.
Prosnitz R, Patwardhan M, Samsa G, Mantyh C, Fisher D, McCrory D, et al.
Cancer . 2006 Oct; 107(10):2352-60. PMID: 17039499
Background: Chemotherapy (CT) and radiation therapy (RT) are essential components of adjuvant (preoperative or postoperative) therapy for many patients with colorectal cancer (CRC); however, quality measures (QMs) of these critical...